Mechanisms Insights into the Role of CRISPR/CAS9 in Breast Cancer Development

Ruoyu Zhou

2025

Abstract

The function of CRISPR/Cas9 gene editing technology in the evolution and therapy of breast cancer is discussed in this paper. Although existing therapy approaches have many flaws and breast cancer is a high-incidence malignancy in women worldwide, CRISPR/Cas9 technology offers a fresh approach with its precision editing capacity. This paper presents the fundamental idea, method of delivery, and application of CRISPR/Cas9 technology in the treatment of breast cancer together with targeted resistance mechanism, precision therapy, and immune cell modification. Simultaneously, the obstacles that the technology faces—off-target effect, immune response and delivery efficiency—are covered, and potential development paths are hinted at. Expected to be a major turning point in breast cancer treatment, CRISPR/Cas9 technology will provide accurate and successful treatment plans to patients and help to prevent and treat breast cancer to a new age.

Paper Citation

in Harvard Style

Zhou R. (2025). Mechanisms Insights into the Role of CRISPR/CAS9 in Breast Cancer Development. In Proceedings of the 1st International Conference on Biomedical Engineering and Food Science - Volume 1: BEFS; ISBN 978-989-758-789-4, SciTePress, pages 162-167. DOI: 10.5220/0014439900004933

in Bibtex Style

@conference{befs25,
author={Ruoyu Zhou},
title={Mechanisms Insights into the Role of CRISPR/CAS9 in Breast Cancer Development},
booktitle={Proceedings of the 1st International Conference on Biomedical Engineering and Food Science - Volume 1: BEFS},
year={2025},
pages={162-167},
publisher={SciTePress},
organization={INSTICC},
doi={10.5220/0014439900004933},
isbn={978-989-758-789-4},
}

in EndNote Style

TY - CONF

JO - Proceedings of the 1st International Conference on Biomedical Engineering and Food Science - Volume 1: BEFS
TI - Mechanisms Insights into the Role of CRISPR/CAS9 in Breast Cancer Development
SN - 978-989-758-789-4
AU - Zhou R.
PY - 2025
SP - 162
EP - 167
DO - 10.5220/0014439900004933
PB - SciTePress